Viewing Study NCT04035434


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-01-08 @ 8:05 AM
Study NCT ID: NCT04035434
Status: TERMINATED
Last Update Posted: 2025-10-24
First Post: 2019-07-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)
Sponsor: CRISPR Therapeutics AG
Organization: